(Z)-3-Bromo-N’-Hydroxybenzimidamide
98%
- Product Code: 246805
CAS:
1643440-91-8
Molecular Weight: | 215.05 g./mol | Molecular Formula: | C₇H₇BrN₂O |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | Room temperature |
Product Description:
Used as an intermediate in organic synthesis, particularly in the preparation of heterocyclic compounds with potential biological activity. It serves in the development of pharmaceuticals, especially in the design of kinase inhibitors and anti-cancer agents. Its hydroxylamidine group and bromine functionality allow for coupling reactions and cyclization processes, making it valuable in medicinal chemistry for building complex drug-like molecules. Also employed in research settings to probe enzyme inhibition mechanisms, especially in nitric oxide synthase-related pathways.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
0.100 | 10-20 days | £177.57 |
+
-
|
(Z)-3-Bromo-N’-Hydroxybenzimidamide
Used as an intermediate in organic synthesis, particularly in the preparation of heterocyclic compounds with potential biological activity. It serves in the development of pharmaceuticals, especially in the design of kinase inhibitors and anti-cancer agents. Its hydroxylamidine group and bromine functionality allow for coupling reactions and cyclization processes, making it valuable in medicinal chemistry for building complex drug-like molecules. Also employed in research settings to probe enzyme inhibition mechanisms, especially in nitric oxide synthase-related pathways.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
£0.00
£0.00
Total :